MedPath
HSA Approval

POSTINOR 2 TABLET 0.75 mg

SIN11836P

POSTINOR 2 TABLET 0.75 mg

POSTINOR 2 TABLET 0.75 mg

March 5, 2002

PHARMLINE MARKETING PTE. LTD.

PHARMLINE MARKETING PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantPHARMLINE MARKETING PTE. LTD.
Licence HolderPHARMLINE MARKETING PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

G03AD01

levonorgestrel

Manufacturer Information

PHARMLINE MARKETING PTE. LTD.

CHEMICAL WORKS OF GEDEON RICHTER PLC

Active Ingredients

LEVONORGESTREL

0.75 mg

Levonorgestrel

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

POSTINOR 2 TABLET 0.75 mg - HSA Approval | MedPath